查詢結果分析
相關文獻
- 移植後的高血壓
- 腎臟移植後的高血壓治療
- 腎臟移植後之高血壓
- 腎臟移植病人之營養照護
- C型肝炎與腎臟移植
- AROTINOLOL治療原發性高血壓的臨床研究
- 運動對高血壓的影響
- Unexpected Pheochromocytoma--A Case Report of Anesthesia in a Uremic Patient
- Relationship between Microalbuminuria, Left Ventricular Mass and Function in Essential Hypertension
- The Effect of Sphenopalatine Postganglionic Neurotomy on the Alteration of Local Cerebral Blood Flow of Normotensive and Hypertensive Rats in Acute Cold Stress
頁籤選單縮合
題 名 | 移植後的高血壓=Hypertension after Kidney Transplantation |
---|---|
作 者 | 陳致中; 吳明儒; 徐國雄; 鄭志雄; | 書刊名 | 腎臟與透析 |
卷 期 | 28:1 2016.03[民105.03] |
頁 次 | 頁14-18 |
專 輯 | 透析治療與腎臟移植之比較專輯 |
分類號 | 415.382 |
關鍵詞 | 腎臟移植; 高血壓; 改善全球腎臟病預後組織臨床指引; Kidney transplantation; Hypertension; KDIGO guideline; |
語 文 | 中文(Chinese) |
中文摘要 | 對一般大眾而言,控制血壓已證實可預防心血管疾病和延緩慢性腎臟病的進展;0對於慢性腎臟病的病人來說,也有證據顯示控制高血壓可減少蛋白尿和減緩腎功能的惡化。對於腎移植接受者,高血壓的盛行率高,也是心血管疾病和慢性移植腎病變的危險因子。雖然在腎移植接受者的血壓目標值為何還沒定論,藥物的副作用也可能較一般人常見,但在改善全球腎臟病預後組織臨床指引仍建議腎移植接受者應監測並控制血壓。 |
英文摘要 | In general population, there is strong evidence that treatment of hypertension is effective in preventing cardiovascular disease and in retarding the progression of chronic kidney disease. There are also evidences in chronic kidney disease that blood pressure reduction reduces proteinuria and slows the rate of decline in kidney function. The incidence of hypertension in kidney transplantation recipients is high, and hypertension is also a risk factor for cardiovascular disease and chronic allograft injury. Although the optimal target of blood pressure in kidney transplantation recipient is not clear and the adverse effects of pharmacological treatment are likely more common than in the general population, monitor and control blood pressure is still recommended in KDIGO (Kidney Disease: Improving Global Outcomes) guideline. |
本系統中英文摘要資訊取自各篇刊載內容。